Scripps Research scientists developed a microchip that rapidly maps antibody-virus interactions using minimal blood samples. This innovation provides faster and clearer insights into immune responses, potentially accelerating vaccine development and antibody discovery. Such technological advances aim to streamline immunological research by revealing hidden binding sites critical to therapeutic design.